Tamoxifen: Mechanism of Action

Tamoxifen MOA:Targeting Estrogen Receptor (ER)/Estrogen Signaling Pathway for Breast Cancer Endocrine Therapy and Resistance

🎯 check Tamoxifen product page

Tamoxifen is a potent, selective estrogen receptor (ER) antagonist. It affects PI3K/AKT and MAPK signaling pathways. By competitively binding to ER and blocking estrogen-dependent transcription, it effectively inhibits breast cancer cell proliferation and promotes apoptosis.

Primary Applications and Mechanism of Action